Excipients in Pharmaceuticals

Published - Aug 2011| Analyst - Paul Evers| Code - PHM010G
Market Research Report Single User License: $2750 Member Price: FREE

Report Highlights

The global excipients market was at $4.6 billion in 2010 and it is expected to reach at $4.9 billion in 2011. It is further anticipated to increase to $6.7 billion by 2016 at a compound annual growth rate (CAGR) of 6.5%.

SCOPE OF REPORT

Excipients in Pharmaceuticals offers coverage of the most important issues surrounding excipients: technological, regulatory, economic, and political issues, and so on.  

Excluded from the study are ingredients for cosmetics, personal care, food, quasi-medical, unorthodox, alternative, home remedies, underground and/or illegal drugs, and veterinary drugs.

This report organizes information from diverse sources into sections entitled Summary, Overview, Technology, Industry Structure, and Company Profiles.  The Summary encapsulates several key conclusions and includes a table of market findings.  The Overview provides deep background information on the most important issues of the day, including the global supply chain crisis, QbD, and legislative prospects.  The Technology section examines excipients by chemical compounds, functional uses, and delivery systems, and as finished products.  The Industry Structure section discusses the market environment, strategies, influences, market shares, international aspects, and other related factors.  The Company Profiles segment provides summaries of more than 120 companies that supply excipients or are relevant to the industry.

ANALYST CREDENTIALS

Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of several previous BCC reports on various aspects of the pharmaceutical marketplace as well as analyses of major trends and the pharmaceutical regulatory environment.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Sep-2009| Analyst - Bob Frost| Code - PHM010F

Report Highlights

  • Overall sales in the global excipients market were worth $4.1 billion in 2008, and increased to an estimated $4.3 billion in 2009. By 2014, it is projected to increase to $5.9 billion, for a 5-year compound annual growth rate (CAGR) of 6.3%.
  • The largest segment of the market, organic chemicals, was valued at $3.8 billion in 2008; this is expected to increase to $4 billion in 2009, and is projected to reach $5.5 billion in 2014, for a 5-year CAGR of 6.4%.
  • Sales in the USP (U.S. Pharmacopeia-grade) Water segment amounted to $79 million in 2008, increased to an estimated $84 million in 2009, and is projected to increase to $104 million in 2014, for a 5-year CAGR of 4.4%.

Published - Jun-2007| Analyst - Norma Corbitt| Code - PHM010E

Report Highlights

  • The chemical compounds used to make excipients are valued at $4.3 billion market value for 2011, up from $3.5 billion in 2006. The dominance of USP water, particularly water for injection, skews the market volume and sets the pace for the anticipated 5.1% average annual market volume growth rate over the next five years.
  • Formulators will continue to use excipients to give their final drug products the necessary or desired functional use or properties. Vehicles, with an estimated 2011 market volume of 9.6 billion pounds, lead due to the large amount of USP water consumed.
  • Fillers follow with an estimated 849 million pounds of excipient chemical compounds being used in that functional category in five years. In terms of market value, the situation is reversed. Fillers come out on top, with an estimated 2011 market value of $1.2 billion, and vehicles drop to third place with $781 million, just below emollients at $816 million.

Published - Dec-2002| Analyst - Charles Forman| Code - PHM010D

Report Highlights

  • In 2001, the global market for pharmaceutical (drug) inert ingredients was an estimated 7.25 billion pounds, of which water, accounted for about 77% of the total.
  • Overall growth of all drug inert ingredients is the order of 5% per year.
  • Injectables, essentially all Rx, constitute the single largest dosage form of excipients used in 2001 with almost 1.9 billion Kgs.
  • Nonaqueous biological use will grow to 563 million Kgs by 2007, an average annual growth rate (AAGR) of 4.5%.

CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report